Analysis of the dynamics of clinical indicators in patients with allergic rhinitis with sensitization to pollen and household allergens using combined allergen-specific immunotherapy
DOI:
https://doi.org/10.26641/2307-0404.2021.4.248161Keywords:
allergic rhinitis, rhinoconjunctivitis, combined allergen-specific immunotherapy, clinical effectAbstract
The aim of this study was to evaluate the clinical efficacy of combined allergen-specific immunotherapy (ASIT) in patients with allergic rhinitis (AR) with combined sensitization to pollen and household allergens. To achieve this goal, 49 patients with AR of working age were examined – 35.5±1.5 years with clinical manifestations of seasonal rhinoconjunctival syndrome with a long period of 9.2±1.1 years, among which there were 25 (51.0%) males and 24 (49%) females. All patients were divided into 2 homogeneous groups by age, sex, duration of the disease, the average number of etiologically significant allergens: the main one – 31 patients who received combined ASIT with solutions of pollen and household allergens and a comparison group – 18 patients for whom only pollen allergens were used. Allergological examination included anamnesis, skin tests with pollen allergens (wormwood, ragweed, quinoa, corn, etc.) and household (house dust, mites, epidermal agents) and / or molecular research methods using the ALEX technology. The quantitative integral assessment of the intensity of AR clinical symptoms was calculated as a total score for the main symptoms. The maximum score for the severity of nasal symptoms – 12, eye - 6, total – 18. The results obtained and their analysis indicate that under the influence of ASIT pollen and household allergens in patients there is a significant and reliable decrease in the intensity of clinical manifestations of seasonal rhinoconjunctive syndrome: nasal manifestations – by 52,2%, conjunctival – by 60%, integral – by 54.3% and an increase of 2.2 times in the percentage of patients in the main group with the disappearance or minimization of clinical symptoms of the disease after treatment compared with patients from the comparison group, which convincingly proves and confirms high efficiency of the selected type of therapy in patients with AR in combination with sensitization to pollen and household allergens.
References
Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018. p. 579. Russian.
Hohunskaia IV, Naumova OA, Kholodenko TYu. [New directions in the diagnosis and treatment of allergic diseases of the upper respiratory tract]. Ukrainskyi pulmonolohichnyi zhurnal. 2016;2:66-67. Russian.
Dytyatkovska EM. [Dynamics of cytokines in patients with hay fever under the influence of ASIT depending on the spectrum of sensitization]. Imunolohiia ta alerholohiia: nauka i praktyka. 2011;3:80-83. Ukrainian.
Dytyatkovska EM, Hohunska IV, Dytiatkovskyi VO. [Allergic rhinitis, epidemiology, pathogenesis, diagnosis, treatment]. Kyiv: Vistka; 2014. p. 208. Ukrainian.
Pukhlyk BM. [Pollinosis: a monograph]. Vinnytsia; 2017 p. 60. Ukrainian.
Pukhlyk BM., Bobelo OL, Dziubenko SP. [House dust mites are the most important allergens in the human environment]. Klinichna imunologhiia. Alerholohiia. Infektolohiia. 2018;108(3):22-26. Russian.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, et al. Allergic Rhinitis and its impacts on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr;63:8-160.
doi: https://doi.org/10.1111/j.1398-9995.2007.01620.x
Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950-58.
Dytyatkovska E, Gashynova K, Panov V. Patters of molecular sensitization in adults in Dnipro region (Ukraine). Allergy. 2019;74:831-2.
Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases. Allergy J Int. 2014;23(8):282-319.
doi: https://doi.org/10.1007/s40629-014-0032-2
Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb:137(2):358-68. doi: https://doi.org/10.1016/j.jaci.2015.12.1300
Pfaar O, Demoly P, Gerth R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854-67. doi: https://doi.org/10.1111/all.12383
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
